Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

134.91
Delayed Data
As of Aug 28
 +0.30 / +0.22%
Today’s Change
124.35
Today|||52-Week Range
173.00
-8.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line47.4M266.9M360.9M484.8M
 
 
 
 
 
Depreciation4.6M17.8M16.6M15.8M
 
 
 
 
 
Total Other Cash Flow-1.5M1.1M-7.6M-12.7M
 
 
 
 
 
Funds From Operations54.6M266.9M346.1M417.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-23.5M18.2M-11.6M10.7M
 
 
 
 
 
Net Cash Flow - Operating Activities78.1M248.7M357.6M406.8M
 
 
 
 
 
 
InvestingIncrease In Investments-4.9M-241.7M-120.7M-43.3M
 
 
 
 
 
Decrease In Investments18.0M4.8M7.2M111.0K
 
 
 
 
 
Capital Expenditures-1.6M-9.5M-21.2M-20.0M
 
 
 
 
 
Fixed Asset Disposal28.0K1.0K8.0K217.0K
 
 
 
 
 
Other Investing - Uses0.00-5.0M-34.0M-31.1M
 
 
 
 
Other Investing - Sources4.0M8.2M0.002.1M
 
 
 
 
Net Cash Flow Investing15.6M-243.9M-173.3M-92.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-6.6M-10.7M-11.9M-10.9M
 
 
 
 
 
Net Proceeds Stock Sale7.0K6.6M1.3M26.0K
 
 
 
 
 
Common Preferred Redeemed0.000.00-193.0M0.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00838.0K149.0K0.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-6.6M-3.3M-203.5M-10.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.2M-2.4M-8.2M-32.1M
 
 
 
 
 
 
Net Change In Cash87.1M1.4M-19.1M303.8M